Valneva SE (VALN) EBT (2021 - 2026)
Valneva SE (VALN) reported EBT of -$36.6 million for Q1 2026, down 348.31% on a YoY basis from $14.7 million in Q1 2025, and up 38.47% sequentially from -$59.5 million in Q4 2025.
Valneva SE (VALN) EBT (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of EBT data on file, last reported at -$36.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 348.31% year-over-year to -$36.6 million; the trailing twelve-month figure through Mar 2026 stood at -$160.2 million (down 90.79% YoY), and the FY2025 full-year result was -$132.8 million, down 968.55% from the prior year.
- EBT rose to -$36.6 million in Q1 2026, from -$59.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of $72.9 million in Q3 2022 to a low of -$153.3 million in Q2 2022.
- A 5-year average of -$26.2 million and a median of -$28.7 million in 2022 frame the typical range for EBT.
- Across the five-year window, EBT soared 426.81% in 2024 and slumped 348.31% in 2026, its largest moves.
- Tracing VALN's EBT over 5 years: stood at -$48.9 million in 2022, then soared by 37.8% to -$30.4 million in 2023, then retreated by 13.7% to -$34.6 million in 2024, then plunged by 72.01% to -$59.5 million in 2025, then jumped by 38.47% to -$36.6 million in 2026.
- Business Quant data shows VALN's EBT at -$36.6 million in Q1 2026, -$59.5 million in Q4 2025, and -$50.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -35.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.56 Mn |
| Dec 31, 2025 | -58.13 Mn |
| Sep 30, 2025 | -49.47 Mn |
| Jun 30, 2025 | -13.44 Mn |
| Mar 31, 2025 | -8.83 Mn |
| Dec 31, 2024 | -36.81 Mn |
| Sep 30, 2024 | -14.74 Mn |
| Jun 30, 2024 | -28.56 Mn |
| Mar 31, 2024 | 67.05 Mn |
| Dec 31, 2023 | -32.15 Mn |
| Sep 30, 2023 | -35.90 Mn |
| Jun 30, 2023 | -23.42 Mn |
| Mar 31, 2023 | -20.76 Mn |
| Dec 31, 2022 | -54.51 Mn |
| Sep 30, 2022 | 82.29 Mn |
| Jun 30, 2022 | -163.50 Mn |
| Mar 31, 2022 | -29.06 Mn |
| Dec 31, 2021 | 198.35 Mn |
| Sep 30, 2021 | -180.43 Mn |
| Jun 30, 2021 | -65.61 Mn |